دورية أكاديمية
أعرض في EDS

Chronic liver disease is an important risk factor for worse outcomes in acute pancreatitis: a systematic review and meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Chronic liver disease is an important risk factor for worse outcomes in acute pancreatitis: a systematic review and meta-analysis.
المؤلفون: Hoferica J; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Clinic of Internal Medicine - Gastroenterology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia., Borbély RZ; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Medical Imaging, Bajcsy-Zsilinszky Hospital and Clinic, Budapest, Hungary., Aghdam AN; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary., Szalai EÁ; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Restorative Dentistry and Endodontics, Semmelweis University, Budapest, Hungary., Zolcsák Á; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary., Veres DS; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Biophysics and Radiation Biology, Semmelweis University, Budapest, Hungary., Hagymási K; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Surgery, Transplantation and Gastroenterology, Semmelweis University, Budapest, Hungary., Erőss B; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary., Hegyi P; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.; Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for Research Development and Innovation, University of Szeged, Szeged, Hungary., Bánovčin P; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.; Clinic of Internal Medicine - Gastroenterology, Jessenius Faculty of Medicine in Martin, Comenius University, Bratislava, Slovakia., Hegyi PJ; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary. hegyi.peter1@semmelweis-univ.hu.; Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary. hegyi.peter1@semmelweis-univ.hu.
المصدر: Scientific reports [Sci Rep] 2024 Jul 19; Vol. 14 (1), pp. 16723. Date of Electronic Publication: 2024 Jul 19.
نوع المنشور: Journal Article; Systematic Review; Meta-Analysis
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : Nature Publishing Group, copyright 2011-
مواضيع طبية MeSH: Pancreatitis*/mortality , Pancreatitis*/complications, Humans ; Risk Factors ; Liver Diseases/mortality ; Liver Diseases/complications ; Systemic Inflammatory Response Syndrome/complications ; Systemic Inflammatory Response Syndrome/mortality ; Chronic Disease ; Acute Disease ; Odds Ratio
مستخلص: Chronic liver diseases (CLD) affect 1.5 billion patients worldwide, with dramatically increasing incidence in recent decades. It has been hypothesized that the chronic hyperinflammation associated with CLD may increase the risk of a more severe course of acute pancreatitis (AP). This study aims to investigate the underlying impact of CLD on the outcomes of AP. A systematic search was conducted in Embase, Medline, and Central databases until October 2022. Studies investigating patients with acute pancreatitis and CLD, were included in the meta-analysis. A total of 14,963 articles were screened, of which 36 were eligible to be included. CLD was a risk factor for increased mortality with an odds ratio (OR) of 2.53 (CI 1.30 to 4.93, p = 0.01). Furthermore, renal, cardiac, and respiratory failures were more common in the CLD group, with ORs of 1.92 (CI 1.3 to 2.83, p = 0.01), 2.11 (CI 0.93 to 4.77, p = 0.062) and 1.99 (CI 1.08 to 3.65, p = 0.033), respectively. Moreover, the likelihood of developing Systemic Inflammatory Response Syndrome (SIRS) was significantly higher, with an OR of 1.95 (CI 1.03 to 3.68, p = 0.042). CLD is an important risk factor for worse outcomes in AP pancreatitis, leading to higher mortality and increased rates of local and systemic complications.
(© 2024. The Author(s).)
References: Ann Intern Med. 2016 Oct 04;165(7):482-490. (PMID: 27454310)
J Comput Assist Tomogr. 2012 Jul-Aug;36(4):400-5. (PMID: 22805667)
Gut. 2013 Jan;62(1):102-11. (PMID: 23100216)
J Clin Med. 2022 Dec 30;12(1):. (PMID: 36615090)
Front Physiol. 2019 Sep 20;10:1202. (PMID: 31620021)
J Clin Med. 2020 May 19;9(5):. (PMID: 32438747)
United European Gastroenterol J. 2023 May;11(4):371-382. (PMID: 37062947)
Lancet. 2020 Sep 5;396(10252):726-734. (PMID: 32891214)
Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275)
Ann Intern Med. 2013 Feb 19;158(4):280-6. (PMID: 23420236)
Gastroenterology. 2023 Sep;165(3):682-695. (PMID: 37247642)
J Clin Gastroenterol. 2015 Sep;49(8):690-6. (PMID: 25291348)
Pancreatology. 2020 Jun;20(4):608-616. (PMID: 32402696)
Pancreatology. 2021 Oct;21(7):1237-1246. (PMID: 34332908)
World J Gastroenterol. 2021 Mar 21;27(11):990-1005. (PMID: 33776368)
Eur J Intern Med. 2022 Aug;102:54-62. (PMID: 35672219)
J Lab Physicians. 2019 Jul-Sep;11(3):259-264. (PMID: 31579249)
Gut. 2022 Dec;71(12):2601-2602. (PMID: 35046088)
Gastroenterol Res Pract. 2017;2017:4532320. (PMID: 28536603)
BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
Dig Dis Sci. 2019 Feb;64(2):553-560. (PMID: 30465178)
Int J Gen Med. 2022 Sep 05;15:7017-7028. (PMID: 36090708)
Sci Rep. 2021 Dec 17;11(1):24158. (PMID: 34921151)
Abdom Radiol (NY). 2021 Apr;46(4):1618-1628. (PMID: 32936420)
World J Gastroenterol. 2014 Jun 21;20(23):7223-30. (PMID: 24966593)
Gut. 2019 Jun;68(6):1044-1051. (PMID: 29950344)
Gastroenterology. 2019 Jan;156(1):254-272.e11. (PMID: 30315778)
Eur J Intern Med. 2017 Mar;38:73-78. (PMID: 27825671)
J Gastrointest Surg. 2007 Jun;11(6):733-42. (PMID: 17417710)
Biomed Res Int. 2019 Jan 22;2019:9583790. (PMID: 30805370)
Res Synth Methods. 2021 Jan;12(1):55-61. (PMID: 32336025)
PLoS One. 2015 Nov 16;10(11):e0142278. (PMID: 26571385)
Hepatology. 2022 Mar;75(3):600-609. (PMID: 34528267)
Ann Transl Med. 2022 Jun;10(12):676. (PMID: 35845515)
Crit Care Med. 1999 Apr;27(4):749-55. (PMID: 10321665)
J Transl Med. 2022 Jan 3;20(1):2. (PMID: 34980174)
Dig Dis Sci. 2021 Aug;66(8):2795-2804. (PMID: 32892261)
J Family Med Prim Care. 2022 Jun;11(6):3360-3367. (PMID: 36119312)
Nat Med. 2021 Aug;27(8):1317-1319. (PMID: 34312557)
J Clin Exp Hepatol. 2019 Jul-Aug;9(4):497-505. (PMID: 31516266)
Pancreatology. 2020 Jan;20(1):44-50. (PMID: 31734110)
Clin Transl Med. 2022 Jun;12(6):e842. (PMID: 35653504)
Diagn Interv Imaging. 2022 Sep;103(9):401-407. (PMID: 35501284)
PLoS One. 2021 Nov 22;16(11):e0260309. (PMID: 34807958)
Clin Liver Dis (Hoboken). 2021 Jun 04;17(5):365-370. (PMID: 34136143)
فهرسة مساهمة: Keywords: Acute pancreatitis; Cirrhosis; Metabolic-associated fatty liver disease; Nonalcoholic fatty liver disease; Steatotic liver disease
تواريخ الأحداث: Date Created: 20240719 Date Completed: 20240719 Latest Revision: 20240805
رمز التحديث: 20240805
مُعرف محوري في PubMed: PMC11271551
DOI: 10.1038/s41598-024-66710-w
PMID: 39030187
قاعدة البيانات: MEDLINE
الوصف
تدمد:2045-2322
DOI:10.1038/s41598-024-66710-w